The genetic disease in question is Pelizaeus-Merzbacher Disease ("PMD"), a serious, sex-linked genetic disorder.
What does PMD stand for?
PMD stands for Pelizaeus-Merzbacher Disease
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of PMD
We have 206 other meanings of PMD in our Acronym Attic
- Adobe PageMaker 7.0 document (file extension)
- Pakistan Meteorological Department
- Pale Morning Dun (Fly Fishing)
- Palmdale (Amtrak station code; Palmdale, CA)
- Palmdale, CA, USA - Air Force 42 (Airport Code)
- Parrish - Microphone Doctor (rap artist)
- Parrish Making Dollars (rap artist)
- Partial Match Domain (search engine optimization)
- Partially-Matched Detector
- Pays Moins Developpes (French: Less Developed Countries)
Samples in periodicals archive:
In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, the Company has shown preliminary evidence of progressive and durable donor- derived myelination in all four patients transplanted with HuCNS-SC cells.
Patients suffering from Pelizaeus-Merzbacher disease struggle to produce a fatty sheath around their nerves, which is essential for function.
Two weeks after being surgically transplanted into either fetal or newborn rats with a congenital disease identical to the rare human myelin disorder Pelizaeus-Merzbacher disease, the laboratory-grown cells had developed into numerous myelin sheaths around nerve fibers previously without myelin.
Their afflicted sons - Vincent, 14, Russell, six, Nathan, four, and two- year-old Damian - all suffer from Pelizaeus-Merzbacher Disease, which is so rare that only 22 families in the country have been diagnosed as victims.
StemCells has also initiated at the University of California, San Francisco (UCSF) Children's Hospital a Phase I trial of the HuCNS-SC cells in Pelizaeus-Merzbacher Disease (PMD), a fatal myelination disorder that primarily afflicts children.
R Tina (September 2001) has a 2-year-old son with Pelizaeus-Merzbacher disease (a rare inherited disease of the central nervous system associated with progressive deterioration of the white matter of the brain) whose head sweats profusely at night, interrupting his sleep.
StemCells has also announced plans to initiate at the University of California, San Francisco (UCSF) Children's Hospital a Phase I trial of its HuCNS-SC cells in Pelizaeus-Merzbacher Disease (PMD), a fatal myelination disorder that primarily affects young children.